Peripheral Retina Robotically Aligned OCT Study
Launched by DUKE UNIVERSITY · Jun 5, 2024
Trial Information
Current as of June 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The Peripheral Retina Robotically Aligned OCT Study is exploring a new imaging technology called optical coherence tomography (OCT) to better view the edges of the retina, which is the light-sensitive layer at the back of the eye. Current OCT systems struggle to capture images from this area, so researchers are developing a robotic OCT system that can help doctors take clearer images of the peripheral retina more easily. This study aims to improve both the imaging and treatment options for retinal diseases.
To join the study, participants must be healthy adults aged 18 and older who are willing to consent to take part. Those with certain eye conditions, like infections or severe cataracts, will not be eligible. Participants can expect to help researchers test this new technology, which could lead to better eye care in the future. The study is not yet recruiting participants, but it is an exciting step toward enhancing how we understand and treat retinal diseases.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subject is able and willing to consent to study participation
- • Subject is more than 18 years of age
- • Healthy adult volunteers without known ocular issues other than refractive error
- Exclusion Criteria:
- • Subject is unwilling or unable to provide consent
- • Subject is less than 18 years of age
- • Students or employees under direct supervision of the investigators
- • Subjects with eye trauma, infection of the anterior ocular tissues or corneal conditions like keratoconus, Peter's anomaly, corneal edema, dense cataracts obscuring the retina and dense capsule opacities in pseudophakes
- • The investigators will not exclude subjects based on eyes being phakic, pseudo-phakic, or aphakic.
About Duke University
Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Patients applied
Trial Officials
Cynthia A Toth, MD
Principal Investigator
Duke University Eye Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported